TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Drug-Resistant Tuberculosis Treatment Market Research Report 2024-2030(Status and Outlook)

Global Drug-Resistant Tuberculosis Treatment Market Research Report 2024-2030(Status and Outlook)

  • Category:Life Sciences
  • Published on : 29 May 2024
  • Pages :137
  • Formats:
  • Report Code:SMR-7957034
OfferClick for best price

Best Price: $2600

DrugResistant Tuberculosis Treatment Market Size, Share 2024


Report Overview

This report provides a deep insight into the global Drug-Resistant Tuberculosis Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug-Resistant Tuberculosis Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug-Resistant Tuberculosis Treatment market in any manner.

Global Drug-Resistant Tuberculosis Treatment Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi

Novartis AG

Endo International plc

CMP Pharma

STI Pharma LLC

Akorn Incorporated

Lupin

Johnson & Johnson Services Inc.

Macleods Pharmaceuticals Ltd

Pfizer Inc

Hikma Pharmaceuticals PLC

Lannett

Mylan N.V.

Teva Pharmaceutical Industries Ltd

Fresenius Kabi AG

Market Segmentation (by Type)

First-Line Anti-TB Drugs

Second-Line Anti-TB Drugs

Others

Market Segmentation (by Application)

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Others

Geographic Segmentation

? North America (USA, Canada, Mexico)

? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

? South America (Brazil, Argentina, Columbia, Rest of South America)

? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

? Industry drivers, restraints, and opportunities covered in the study

? Neutral perspective on the market performance

? Recent industry trends and developments

? Competitive landscape & strategies of key players

? Potential & niche segments and regions exhibiting promising growth covered

? Historical, current, and projected market size, in terms of value

? In-depth analysis of the Drug-Resistant Tuberculosis Treatment Market

? Overview of the regional outlook of the Drug-Resistant Tuberculosis Treatment Market:

Key Reasons to Buy this Report:

? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

? This enables you to anticipate market changes to remain ahead of your competitors

? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

? Provision of market value (USD Billion) data for each segment and sub-segment

? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis

? Provides insight into the market through Value Chain

? Market dynamics scenario, along with growth opportunities of the market in the years to come

? 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Resistant Tuberculosis Treatment Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Report Attributes Report Details
Report Title Global Drug-Resistant Tuberculosis Treatment Market Research Report 2024-2030(Status and Outlook)
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 137 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Drug-Resistant Tuberculosis Treatment
1.2 Key Market Segments
1.2.1 Drug-Resistant Tuberculosis Treatment Segment by Type
1.2.2 Drug-Resistant Tuberculosis Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Drug-Resistant Tuberculosis Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Drug-Resistant Tuberculosis Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Drug-Resistant Tuberculosis Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Drug-Resistant Tuberculosis Treatment Market Competitive Landscape
3.1 Global Drug-Resistant Tuberculosis Treatment Sales by Manufacturers (2019-2024)
3.2 Global Drug-Resistant Tuberculosis Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug-Resistant Tuberculosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug-Resistant Tuberculosis Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug-Resistant Tuberculosis Treatment Sales Sites, Area Served, Product Type
3.6 Drug-Resistant Tuberculosis Treatment Market Competitive Situation and Trends
3.6.1 Drug-Resistant Tuberculosis Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug-Resistant Tuberculosis Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Drug-Resistant Tuberculosis Treatment Industry Chain Analysis
4.1 Drug-Resistant Tuberculosis Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Drug-Resistant Tuberculosis Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Drug-Resistant Tuberculosis Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Type (2019-2024)
6.3 Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Drug-Resistant Tuberculosis Treatment Price by Type (2019-2024)
7 Drug-Resistant Tuberculosis Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Resistant Tuberculosis Treatment Market Sales by Application (2019-2024)
7.3 Global Drug-Resistant Tuberculosis Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Drug-Resistant Tuberculosis Treatment Sales Growth Rate by Application (2019-2024)
8 Drug-Resistant Tuberculosis Treatment Market Segmentation by Region
8.1 Global Drug-Resistant Tuberculosis Treatment Sales by Region
8.1.1 Global Drug-Resistant Tuberculosis Treatment Sales by Region
8.1.2 Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Drug-Resistant Tuberculosis Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug-Resistant Tuberculosis Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug-Resistant Tuberculosis Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug-Resistant Tuberculosis Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug-Resistant Tuberculosis Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Sanofi
9.1.1 Sanofi Drug-Resistant Tuberculosis Treatment Basic Information
9.1.2 Sanofi Drug-Resistant Tuberculosis Treatment Product Overview
9.1.3 Sanofi Drug-Resistant Tuberculosis Treatment Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Drug-Resistant Tuberculosis Treatment SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 Novartis AG
9.2.1 Novartis AG Drug-Resistant Tuberculosis Treatment Basic Information
9.2.2 Novartis AG Drug-Resistant Tuberculosis Treatment Product Overview
9.2.3 Novartis AG Drug-Resistant Tuberculosis Treatment Product Market Performance
9.2.4 Novartis AG Business Overview
9.2.5 Novartis AG Drug-Resistant Tuberculosis Treatment SWOT Analysis
9.2.6 Novartis AG Recent Developments
9.3 Endo International plc
9.3.1 Endo International plc Drug-Resistant Tuberculosis Treatment Basic Information
9.3.2 Endo International plc Drug-Resistant Tuberculosis Treatment Product Overview
9.3.3 Endo International plc Drug-Resistant Tuberculosis Treatment Product Market Performance
9.3.4 Endo International plc Drug-Resistant Tuberculosis Treatment SWOT Analysis
9.3.5 Endo International plc Business Overview
9.3.6 Endo International plc Recent Developments
9.4 CMP Pharma
9.4.1 CMP Pharma Drug-Resistant Tuberculosis Treatment Basic Information
9.4.2 CMP Pharma Drug-Resistant Tuberculosis Treatment Product Overview
9.4.3 CMP Pharma Drug-Resistant Tuberculosis Treatment Product Market Performance
9.4.4 CMP Pharma Business Overview
9.4.5 CMP Pharma Recent Developments
9.5 STI Pharma LLC
9.5.1 STI Pharma LLC Drug-Resistant Tuberculosis Treatment Basic Information
9.5.2 STI Pharma LLC Drug-Resistant Tuberculosis Treatment Product Overview
9.5.3 STI Pharma LLC Drug-Resistant Tuberculosis Treatment Product Market Performance
9.5.4 STI Pharma LLC Business Overview
9.5.5 STI Pharma LLC Recent Developments
9.6 Akorn Incorporated
9.6.1 Akorn Incorporated Drug-Resistant Tuberculosis Treatment Basic Information
9.6.2 Akorn Incorporated Drug-Resistant Tuberculosis Treatment Product Overview
9.6.3 Akorn Incorporated Drug-Resistant Tuberculosis Treatment Product Market Performance
9.6.4 Akorn Incorporated Business Overview
9.6.5 Akorn Incorporated Recent Developments
9.7 Lupin
9.7.1 Lupin Drug-Resistant Tuberculosis Treatment Basic Information
9.7.2 Lupin Drug-Resistant Tuberculosis Treatment Product Overview
9.7.3 Lupin Drug-Resistant Tuberculosis Treatment Product Market Performance
9.7.4 Lupin Business Overview
9.7.5 Lupin Recent Developments
9.8 Johnson and Johnson Services Inc.
9.8.1 Johnson and Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Basic Information
9.8.2 Johnson and Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Product Overview
9.8.3 Johnson and Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Product Market Performance
9.8.4 Johnson and Johnson Services Inc. Business Overview
9.8.5 Johnson and Johnson Services Inc. Recent Developments
9.9 Macleods Pharmaceuticals Ltd
9.9.1 Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Basic Information
9.9.2 Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Product Overview
9.9.3 Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Product Market Performance
9.9.4 Macleods Pharmaceuticals Ltd Business Overview
9.9.5 Macleods Pharmaceuticals Ltd Recent Developments
9.10 Pfizer Inc
9.10.1 Pfizer Inc Drug-Resistant Tuberculosis Treatment Basic Information
9.10.2 Pfizer Inc Drug-Resistant Tuberculosis Treatment Product Overview
9.10.3 Pfizer Inc Drug-Resistant Tuberculosis Treatment Product Market Performance
9.10.4 Pfizer Inc Business Overview
9.10.5 Pfizer Inc Recent Developments
9.11 Hikma Pharmaceuticals PLC
9.11.1 Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Basic Information
9.11.2 Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Product Overview
9.11.3 Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Product Market Performance
9.11.4 Hikma Pharmaceuticals PLC Business Overview
9.11.5 Hikma Pharmaceuticals PLC Recent Developments
9.12 Lannett
9.12.1 Lannett Drug-Resistant Tuberculosis Treatment Basic Information
9.12.2 Lannett Drug-Resistant Tuberculosis Treatment Product Overview
9.12.3 Lannett Drug-Resistant Tuberculosis Treatment Product Market Performance
9.12.4 Lannett Business Overview
9.12.5 Lannett Recent Developments
9.13 Mylan N.V.
9.13.1 Mylan N.V. Drug-Resistant Tuberculosis Treatment Basic Information
9.13.2 Mylan N.V. Drug-Resistant Tuberculosis Treatment Product Overview
9.13.3 Mylan N.V. Drug-Resistant Tuberculosis Treatment Product Market Performance
9.13.4 Mylan N.V. Business Overview
9.13.5 Mylan N.V. Recent Developments
9.14 Teva Pharmaceutical Industries Ltd
9.14.1 Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Basic Information
9.14.2 Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Product Overview
9.14.3 Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Product Market Performance
9.14.4 Teva Pharmaceutical Industries Ltd Business Overview
9.14.5 Teva Pharmaceutical Industries Ltd Recent Developments
9.15 Fresenius Kabi AG
9.15.1 Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Basic Information
9.15.2 Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Product Overview
9.15.3 Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Product Market Performance
9.15.4 Fresenius Kabi AG Business Overview
9.15.5 Fresenius Kabi AG Recent Developments
10 Drug-Resistant Tuberculosis Treatment Market Forecast by Region
10.1 Global Drug-Resistant Tuberculosis Treatment Market Size Forecast
10.2 Global Drug-Resistant Tuberculosis Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug-Resistant Tuberculosis Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Drug-Resistant Tuberculosis Treatment Market Size Forecast by Region
10.2.4 South America Drug-Resistant Tuberculosis Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug-Resistant Tuberculosis Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Drug-Resistant Tuberculosis Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Drug-Resistant Tuberculosis Treatment by Type (2025-2030)
11.1.2 Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Drug-Resistant Tuberculosis Treatment by Type (2025-2030)
11.2 Global Drug-Resistant Tuberculosis Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Drug-Resistant Tuberculosis Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Drug-Resistant Tuberculosis Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug-Resistant Tuberculosis Treatment Market Size Comparison by Region (M USD)
Table 5. Global Drug-Resistant Tuberculosis Treatment Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Drug-Resistant Tuberculosis Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Drug-Resistant Tuberculosis Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Resistant Tuberculosis Treatment as of 2022)
Table 10. Global Market Drug-Resistant Tuberculosis Treatment Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Drug-Resistant Tuberculosis Treatment Sales Sites and Area Served
Table 12. Manufacturers Drug-Resistant Tuberculosis Treatment Product Type
Table 13. Global Drug-Resistant Tuberculosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Drug-Resistant Tuberculosis Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug-Resistant Tuberculosis Treatment Market Challenges
Table 22. Global Drug-Resistant Tuberculosis Treatment Sales by Type (Kilotons)
Table 23. Global Drug-Resistant Tuberculosis Treatment Market Size by Type (M USD)
Table 24. Global Drug-Resistant Tuberculosis Treatment Sales (Kilotons) by Type (2019-2024)
Table 25. Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Drug-Resistant Tuberculosis Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Drug-Resistant Tuberculosis Treatment Market Size Share by Type (2019-2024)
Table 28. Global Drug-Resistant Tuberculosis Treatment Price (USD/Ton) by Type (2019-2024)
Table 29. Global Drug-Resistant Tuberculosis Treatment Sales (Kilotons) by Application
Table 30. Global Drug-Resistant Tuberculosis Treatment Market Size by Application
Table 31. Global Drug-Resistant Tuberculosis Treatment Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Drug-Resistant Tuberculosis Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Drug-Resistant Tuberculosis Treatment Market Share by Application (2019-2024)
Table 35. Global Drug-Resistant Tuberculosis Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Drug-Resistant Tuberculosis Treatment Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Drug-Resistant Tuberculosis Treatment Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Drug-Resistant Tuberculosis Treatment Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Drug-Resistant Tuberculosis Treatment Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Drug-Resistant Tuberculosis Treatment Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Drug-Resistant Tuberculosis Treatment Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Drug-Resistant Tuberculosis Treatment Basic Information
Table 44. Sanofi Drug-Resistant Tuberculosis Treatment Product Overview
Table 45. Sanofi Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Drug-Resistant Tuberculosis Treatment SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. Novartis AG Drug-Resistant Tuberculosis Treatment Basic Information
Table 50. Novartis AG Drug-Resistant Tuberculosis Treatment Product Overview
Table 51. Novartis AG Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis AG Business Overview
Table 53. Novartis AG Drug-Resistant Tuberculosis Treatment SWOT Analysis
Table 54. Novartis AG Recent Developments
Table 55. Endo International plc Drug-Resistant Tuberculosis Treatment Basic Information
Table 56. Endo International plc Drug-Resistant Tuberculosis Treatment Product Overview
Table 57. Endo International plc Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Endo International plc Drug-Resistant Tuberculosis Treatment SWOT Analysis
Table 59. Endo International plc Business Overview
Table 60. Endo International plc Recent Developments
Table 61. CMP Pharma Drug-Resistant Tuberculosis Treatment Basic Information
Table 62. CMP Pharma Drug-Resistant Tuberculosis Treatment Product Overview
Table 63. CMP Pharma Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. CMP Pharma Business Overview
Table 65. CMP Pharma Recent Developments
Table 66. STI Pharma LLC Drug-Resistant Tuberculosis Treatment Basic Information
Table 67. STI Pharma LLC Drug-Resistant Tuberculosis Treatment Product Overview
Table 68. STI Pharma LLC Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. STI Pharma LLC Business Overview
Table 70. STI Pharma LLC Recent Developments
Table 71. Akorn Incorporated Drug-Resistant Tuberculosis Treatment Basic Information
Table 72. Akorn Incorporated Drug-Resistant Tuberculosis Treatment Product Overview
Table 73. Akorn Incorporated Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Akorn Incorporated Business Overview
Table 75. Akorn Incorporated Recent Developments
Table 76. Lupin Drug-Resistant Tuberculosis Treatment Basic Information
Table 77. Lupin Drug-Resistant Tuberculosis Treatment Product Overview
Table 78. Lupin Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Lupin Business Overview
Table 80. Lupin Recent Developments
Table 81. Johnson and Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Basic Information
Table 82. Johnson and Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Product Overview
Table 83. Johnson and Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Johnson and Johnson Services Inc. Business Overview
Table 85. Johnson and Johnson Services Inc. Recent Developments
Table 86. Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Basic Information
Table 87. Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Product Overview
Table 88. Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Macleods Pharmaceuticals Ltd Business Overview
Table 90. Macleods Pharmaceuticals Ltd Recent Developments
Table 91. Pfizer Inc Drug-Resistant Tuberculosis Treatment Basic Information
Table 92. Pfizer Inc Drug-Resistant Tuberculosis Treatment Product Overview
Table 93. Pfizer Inc Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Pfizer Inc Business Overview
Table 95. Pfizer Inc Recent Developments
Table 96. Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Basic Information
Table 97. Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Product Overview
Table 98. Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hikma Pharmaceuticals PLC Business Overview
Table 100. Hikma Pharmaceuticals PLC Recent Developments
Table 101. Lannett Drug-Resistant Tuberculosis Treatment Basic Information
Table 102. Lannett Drug-Resistant Tuberculosis Treatment Product Overview
Table 103. Lannett Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Lannett Business Overview
Table 105. Lannett Recent Developments
Table 106. Mylan N.V. Drug-Resistant Tuberculosis Treatment Basic Information
Table 107. Mylan N.V. Drug-Resistant Tuberculosis Treatment Product Overview
Table 108. Mylan N.V. Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Mylan N.V. Business Overview
Table 110. Mylan N.V. Recent Developments
Table 111. Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Basic Information
Table 112. Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Product Overview
Table 113. Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Teva Pharmaceutical Industries Ltd Business Overview
Table 115. Teva Pharmaceutical Industries Ltd Recent Developments
Table 116. Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Basic Information
Table 117. Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Product Overview
Table 118. Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Fresenius Kabi AG Business Overview
Table 120. Fresenius Kabi AG Recent Developments
Table 121. Global Drug-Resistant Tuberculosis Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Drug-Resistant Tuberculosis Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Drug-Resistant Tuberculosis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Drug-Resistant Tuberculosis Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Drug-Resistant Tuberculosis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Drug-Resistant Tuberculosis Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Drug-Resistant Tuberculosis Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Drug-Resistant Tuberculosis Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Drug-Resistant Tuberculosis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Drug-Resistant Tuberculosis Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Drug-Resistant Tuberculosis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Drug-Resistant Tuberculosis Treatment Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Drug-Resistant Tuberculosis Treatment Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Drug-Resistant Tuberculosis Treatment Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Drug-Resistant Tuberculosis Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug-Resistant Tuberculosis Treatment Market Size (M USD), 2019-2030
Figure 5. Global Drug-Resistant Tuberculosis Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Drug-Resistant Tuberculosis Treatment Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug-Resistant Tuberculosis Treatment Market Size by Country (M USD)
Figure 11. Drug-Resistant Tuberculosis Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Drug-Resistant Tuberculosis Treatment Revenue Share by Manufacturers in 2023
Figure 13. Drug-Resistant Tuberculosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Drug-Resistant Tuberculosis Treatment Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drug-Resistant Tuberculosis Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Drug-Resistant Tuberculosis Treatment Market Share by Type
Figure 18. Sales Market Share of Drug-Resistant Tuberculosis Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Drug-Resistant Tuberculosis Treatment by Type in 2023
Figure 20. Market Size Share of Drug-Resistant Tuberculosis Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Drug-Resistant Tuberculosis Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug-Resistant Tuberculosis Treatment Market Share by Application
Figure 24. Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Application in 2023
Figure 26. Global Drug-Resistant Tuberculosis Treatment Market Share by Application (2019-2024)
Figure 27. Global Drug-Resistant Tuberculosis Treatment Market Share by Application in 2023
Figure 28. Global Drug-Resistant Tuberculosis Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Drug-Resistant Tuberculosis Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Drug-Resistant Tuberculosis Treatment Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Drug-Resistant Tuberculosis Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Drug-Resistant Tuberculosis Treatment Sales Market Share by Country in 2023
Figure 37. Germany Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Drug-Resistant Tuberculosis Treatment Sales Market Share by Region in 2023
Figure 44. China Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (Kilotons)
Figure 50. South America Drug-Resistant Tuberculosis Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Drug-Resistant Tuberculosis Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Drug-Resistant Tuberculosis Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Drug-Resistant Tuberculosis Treatment Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Drug-Resistant Tuberculosis Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Drug-Resistant Tuberculosis Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Drug-Resistant Tuberculosis Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Drug-Resistant Tuberculosis Treatment Market Share Forecast by Application (2025-2030)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount